Natera, Inc. (NTRA): EBITDA
-$268.15M
Year ended 2025-12-31
-$237.01M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$268.15M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$191.33M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$422.15M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$524.34M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$456.92M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$207.66M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$108.56M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$107.13M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$128.20M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$94.87M | n/c | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$54.30M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $5.81M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$22.74M | n/a | 2016-03-24, From 2013-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | -$268.15M | n/m |
| RadNet, Inc. (RDNT) | 2025-12-31 | $198.09M | -13.8% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | -$794.60M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$397.51M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $67.73M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $79.19M | +100.0% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $2.13B | +15.6% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $2.07B | +19.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$15.76M | n/m |
Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗